The SIAscope is a Class 2 medical device that captures five separate images of pigmented lesions. It provides a contact dermoscopic image and four spectrophotometric images that penetrate 2mm below the skin’s surface. These additional images reveal unusual morphology or disorganization, enabling dermatologists to make more accurate assessments.
Dr. Trevor ChampagneDermatologist MedX’s technology allows me to assess potentially life-threatening moles or lesions as if the patient were standing right in front of me!
Marisa SpinaPatient My experience with the Medx Scanner was non-invasive, taking only 30 seconds. Right after images were shown on the computer, I had an appointment with a dermatologist within 3 days. It turned out to be melanoma. So, what I want to say is that it takes 30 seconds to save a life!
Danielle DupuisPatient I was concerned about a mole on my back and I contacted MedX, they did a scan and determined it was Melanoma stage 1.
It was sent directly to a dermatologist; a couple days later I’m getting it removed and now I’m okay. I believe that Medx is an amazing company, I think that all of their scanners should be everywhere in the world.
This scanner is life-changing for everyone.
Read full report (PDF) Identifying timely topics and trends in the sub-$200 million market. Research Type: Emerging | Timeliness: Current | Date: March 05, 2024MedX Health Corp. TSXV: MDX | …
Health Partners, the UK’s largest non-hospital private healthcare services provider, with over two million patients across 550+ corporate, insurance and government clients, announced its intention to partner with MedX after …
MISSISSAUGA, ON — January 25, 2024 – MedX Health Corp. (“MedX” or the “Company”) (TSX VENTURE: MDX) is pleased to announce that it has appointed Dr. Paul Cohen, a board-certified dermatologist and …
If you need more information about our services or our business vision please reach out and we will connect you with the proper member of our team who can serve you best!
English (Canada) 
Français 
Türkçe